Palliative Care Psychedelics Firm Psyence Completes Newcourt Merger, Goes Public in US
Hospice News
JANUARY 30, 2024
billion by 2027, up from $2 billion in 2020. Canada-based Psyence Biomed has completed a merger with Newcourt Acquisition Corp. NASDAQ: NCAC), making the palliative care-focused psychedelics company publicly traded in the United States. Psyence Biomed is a subsidiary of the Canadian biotech company Psyence Group Inc.
Let's personalize your content